September 15, 2023 · STOCK Act disclosure
Representative Josh Gottheimer (Democrat-NJ) sold BioCryst Pharmaceuticals, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on September 15, 2023 and was disclosed on October 15, 2023 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.